News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
516,053 Results
Type
Article (44135)
Company Profile (126)
Press Release (471792)
Section
Business (144660)
Career Advice (2378)
Deals (27873)
Drug Delivery (105)
Drug Development (67711)
Employer Resources (148)
FDA (15539)
Job Trends (11919)
News (263064)
Policy (29544)
Tag
Academia (2282)
Alliances (35673)
Alzheimer's disease (1271)
Approvals (15433)
Artificial intelligence (111)
Bankruptcy (300)
Best Places to Work (9061)
Biosimilars (80)
Breast cancer (103)
Cancer (917)
Cardiovascular disease (81)
Career advice (1986)
Cell therapy (211)
Clinical research (53447)
Collaboration (290)
Compensation (173)
COVID-19 (2537)
C-suite (83)
Data (866)
Diabetes (141)
Diagnostics (5064)
Drug pricing (96)
Earnings (56820)
Employer resources (136)
Events (74319)
Executive appointments (220)
FDA (15987)
Funding (241)
Gene therapy (162)
GLP-1 (635)
Government (3789)
Healthcare (14683)
Infectious disease (2617)
Inflammatory bowel disease (96)
Interviews (444)
IPO (13770)
Job creations (3151)
Job search strategy (1659)
Layoffs (446)
Legal (6897)
Lung cancer (155)
Manufacturing (154)
Medical device (11036)
Medtech (11039)
Mergers & acquisitions (14133)
Metabolic disorders (411)
Neuroscience (1512)
NextGen Class of 2024 (4967)
Non-profit (3155)
Northern California (1183)
Obesity (248)
Opinion (185)
Patents (94)
People (41705)
Phase I (15926)
Phase II (23119)
Phase III (19067)
Pipeline (315)
Policy (80)
Postmarket research (2192)
Preclinical (6450)
Radiopharmaceuticals (200)
Rare diseases (193)
Real estate (4246)
Regulatory (20130)
Research institute (2047)
Resumes & cover letters (400)
Southern California (1020)
Startups (2733)
United States (10623)
Vaccines (611)
Weight loss (208)
Date
Today (17)
Last 7 days (999)
Last 30 days (2911)
Last 365 days (31328)
2024 (27629)
2023 (34981)
2022 (45058)
2021 (48500)
2020 (45512)
2019 (36210)
2018 (27396)
2017 (27804)
2016 (25803)
2015 (27973)
2014 (21774)
2013 (17791)
2012 (18963)
2011 (19381)
2010 (17504)
Location
Africa (667)
Arizona (134)
Asia (30418)
Australia (5319)
California (2570)
Canada (894)
China (165)
Colorado (109)
Connecticut (127)
Europe (73785)
Florida (375)
Georgia (90)
Illinois (244)
Indiana (146)
Maryland (500)
Massachusetts (2091)
Michigan (111)
Minnesota (201)
New Jersey (770)
New York (753)
North Carolina (616)
Northern California (1183)
Ohio (102)
Pennsylvania (680)
South America (1031)
Southern California (1020)
Texas (342)
Washington State (300)
516,053 Results for "procaps s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Procaps Issues Shareholder Letter from New CEO
Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira, CEO of Procaps.
February 5, 2024
·
4 min read
BioMidwest
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
Procaps Group announced that it has received a letter from the Nasdaq Stock Market, dated May 16, 2024, notifying the Company that it is not in compliance with the requirements for continued listing set forth in Nasdaq Listing Rule 5250 because it did not timely file its annual report on Form 20-F for the year ended December 31, 2023.
May 20, 2024
·
3 min read
Business
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
Procaps Group, a leading integrated LatAm healthcare and pharmaceutical services company, announced that it is conducting a process to explore strategic alternatives to maximize shareholder value.
March 4, 2024
·
5 min read
Business
Procaps Group Reports Third Quarter 2023 Results
Procaps Group, S.A. announced its financial results for the three months ended September 30, 2023 and the nine months ended September 30, 2023.
December 26, 2023
·
8 min read
Business
Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024
Procaps Group announced a strategic leadership transition as Ruben Minski, founder and CEO of Procaps prepares to transition from the role of Chief Executive Officer to focus exclusively on his role as Executive Chairman of the Board, and the appointment of Jose Antonio Vieira as the new Chief Executive Officer of Procaps Group.
November 22, 2023
·
5 min read
Business
Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors
Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the appointment of one new member to its Board of Directors.
October 23, 2023
·
2 min read
BioMidwest
Procaps Group Announces the Expansion of its Oncology Portfolio
Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical services company, announced that it has entered into an agreement with BDR Pharmaceuticals International Pvt. Limited for 27 oncology molecules for Latin America, including 20 TKIs.
September 7, 2023
·
4 min read
Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October
Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, announced today that members of its executive leadership team will participate at two upcoming investor conferences.
September 15, 2023
·
3 min read
Business
Procaps Group Reports Second Quarter 2023 Results
Procaps Group, S.A., a leading integrated international healthcare and pharmaceutical services company, announced its financial results for the three months ended June 30, 2023 and the six months ended June 30, 2023.
September 5, 2023
·
7 min read
BioMidwest
Procaps Group Publishes White Paper on Innovative Gummy Technology
Procaps Group, S.A. announced the availability of a new white paper focused on gummy products, its revolutionary gummy technology, titled “Revolutionary Gummy Technology That Solves for The Supply Chain Constraints of Other Gummy Formats and Enhances Consumer Experience”.
August 16, 2023
·
4 min read
1 of 51,606
Next